CD8A and neoplasm: Collectively, we show that checkpoint blockade immunotherapy in this mouse model did not profoundly influence the phenotypic profiles of peripheral neoantigen-specific CD8+ T cells but predominantly affected marker expression of antigen-experienced T cells present in the tumour.